MENU
APLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Apellis Pharmaceuticals (APLS) Ownership - Who owns Apellis Pharmaceuticals?
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade... Show more
Industry: #Medical Distributors
Profile
Industry
Medical Distributors
Address
100 Fifth Avenue
Phone
+1 617 977-5700
Employees
706
Web
https://www.apellis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.89B
P/E Ratio
N/A
Total Cash
411.29M
Projected Growth
N/A
Total Debt
469.78M
Revenue
781.37M
Risk (Beta)
-0.11
Dividend Yield
N/A
Total Cash/Share
3.28
Total Debt/Equity
N/A
Revenue/Share
6.31 USD as % of share price
Fundamentals
APLS
Capitalization
2.89B
P/E Ratio
N/A
Risk (Beta)
-0.11
Dividend Yield
N/A
Total Cash
411M
Total Cash/Share
3.28
Total Debt
470M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.31%
Revenue
781M
ROE
N/A
Book Value
229M
P/B Ratio
12.63
Cash Flow
N/A
Earnings
-1.6
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
12K
Current Ratio
4.25
Current Revenue Per Employee
299335.22
Dividends Per Share - Security
N/A
EBITDA
-154.53M
Float
N/A
Float - Current
N/A
Gross Income Margin
80.78
Revenue To Assets
-23.64
Shares Held By Institutions
6.99B
Shares Outstanding - Current
126M
Total Liabilities
657M
Total Volume MTD
N/A
Value
-1
Gain YTD
-28.925
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of therapeutics and drug delivery technologies to address chronic inflammatory diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Medical Distributors
Address
100 Fifth Avenue
Phone
+1 617 977-5700
Employees
706
Web
https://www.apellis.com